﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 15:05:24 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>RaySearch Brings Next-Level Innovation to ASTRO 2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-brings-next-level-innovation-to-astro-2025,c4240404</link><guid isPermaLink="false">cision5220451</guid><description><![CDATA[RaySearch Laboratories AB (publ) is proud to announce its participation at ASTRO in San Francisco, California, September 28-30, where state of the art innovations will be presented under the global campaign Coding Energy to End Cancer. Attendees can watch demonstrations of the treatment planning system RayStation®*, the oncology information system RayCare®*, and the cloud-based oncology analytics system RayIntelligence® during the congress. Demonstrations are booked at booth #2025 or on the event webpage here (https://www.raysearchlabs.com/astro-2025).
At ASTRO 2025, RaySearch will spotlight]]></description><pubDate>Fri, 26 Sep 2025 07:30:00 GMT</pubDate></item><item><title>RaySearch launches RayIntelligence® v2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-launches-rayintelligence--v2025,c4227416</link><guid isPermaLink="false">cision5203999</guid><description><![CDATA[RaySearch Laboratories AB (publ) today announced the release of RayIntelligence®* v2025, a major update to its oncology analytics system designed to transform clinical data into actionable insights. With new tools for building customized dashboards and deeper integration across RaySearch’s product portfolio—including RayStation®* and RayCare®*—the system enables clinics to continuously learn from patient journey data and improve treatment outcomes.
In most clinics, large volumes of oncology data are scattered across separate systems, which makes evidence-based improvements slow and fragile.]]></description><pubDate>Mon, 01 Sep 2025 09:25:00 GMT</pubDate></item><item><title>Proton center in South Korea selects RayStation and RayCare</title><link>https://news.cision.com/raysearch-laboratories/r/proton-center-in-south-korea-selects-raystation-and-raycare,c4226074</link><guid isPermaLink="false">cision5201678</guid><description><![CDATA[RaySearch Laboratories AB (publ) is pleased to announce that Keimyung University Dongsan Medical Center (DSMC) in South Korea has selected the treatment planning system RayStation®* and oncology information system RayCare®* to enable advanced cancer treatment at its new proton center. Installation is scheduled to begin in the second quarter of 2028, with first patient treatments expected by the end of 2029.
DSMC’s Comprehensive Cancer Center is at the forefront of patient-centered cancer care and will be the first top-tier general hospital in South Korea to introduce the ProTom Radiance 330]]></description><pubDate>Thu, 28 Aug 2025 07:45:00 GMT</pubDate></item><item><title>Interim report April - June 2025</title><link>https://news.cision.com/raysearch-laboratories/r/interim-report-april---june-2025,c4215728</link><guid isPermaLink="false">cision5188140</guid><description><![CDATA[SECOND QUARTER (APRIL - JUNE 2025)       

  · Order intake amounted to SEK 241.2 M (290.3)
  · Net sales amounted to SEK 304.9 (318.9)
  · Operating profit amounted to SEK 36.4 M (79.3)
  · Profit after tax amounted to SEK 30.8 M (61.4)
  · Earnings per share before/after dilution amounted to SEK 0.90 (1.79)
  · Cash flow from operating activities amounted to SEK 70.6 M (154.6)
  · Order backlog amounted to SEK 1,665.3 M (1,790.5) at the end of the period

HALF-YEAR (JANUARY - JUNE 2025)  

  · Order intake amounted to SEK 650.8 M (528.8)
  · Net sales amounted to SEK 636.6 M (]]></description><pubDate>Fri, 08 Aug 2025 05:45:00 GMT</pubDate></item><item><title>RaySearch to present innovative news in RayStation, RayCare, and RayIntelligence at AAPM 2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-to-present-innovative-news-in-raystation--raycare--and-rayintelligence-at-aapm-2025,c4211241</link><guid isPermaLink="false">cision5182317</guid><description><![CDATA[RaySearch Laboratories AB (publ) is proud to announce its participation at AAPM in Washington, D.C., July 27-30, where state of the art innovations under the global campaign Coding Energy to End Cancer will be presented. Attendees can take part in demonstrations of the treatment planning system RayStation®*, the oncology information system RayCare®*, and the cloud-based oncology analytics system RayIntelligence® during the congress. Demonstrations are booked at booth #6001 or on the event webpage here (https://www.raysearchlabs.com/aapm-2025/).
At AAPM 2025, RaySearch will spotlight five key]]></description><pubDate>Fri, 25 Jul 2025 06:30:00 GMT</pubDate></item><item><title>AKSM/Oncology selects RayCare and RayStation for a new cancer center</title><link>https://news.cision.com/raysearch-laboratories/r/aksm-oncology-selects-raycare-and-raystation-for-a-new-cancer-center,c4208985</link><guid isPermaLink="false">cision5180068</guid><description><![CDATA[RaySearch Laboratories AB (publ) is pleased to announce that AKSM/Oncology has selected RayCare®* oncology information system and RayStation®* treatment planning system for Advanced Radiation Therapeutics (ART), a new partnership with Urology Associates of The Central Coast in San Luis Obispo in California, USA. The center is expected to open in March 2026 and will provide patients with comprehensive treatment using various techniques. The new center will use RayStation and RayCare together with its Varian TrueBeam** linear accelerators.
ART will be a multidisciplinary center serving the]]></description><pubDate>Mon, 21 Jul 2025 06:30:00 GMT</pubDate></item><item><title>RaySearch and Radiology Oncology Systems in strategic partnership to expand access to cancer care</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-and-radiology-oncology-systems-in-strategic-partnership-to-expand-access-to-cancer-care,c4207484</link><guid isPermaLink="false">cision5179592</guid><description><![CDATA[RaySearch Laboratories AB (publ) and Radiology Oncology Systems, Inc. (ROS) are pleased to announce a strategic partnership, aiming at identifying and pursuing opportunities involving both emerging and existing technologies, with focus on the integration of refurbished linear accelerators with advanced software solutions. The collaboration has already resulted in several agreements.
The purpose of the partnership is to jointly offer comprehensive solutions that expand access to radiation therapy, ensure high-quality care, and strengthen each party’s market position. Today, many fully]]></description><pubDate>Fri, 18 Jul 2025 13:57:03 GMT</pubDate></item><item><title>Invitation to presentation of RaySearch’s interim report for the second quarter of 2025</title><link>https://news.cision.com/raysearch-laboratories/r/invitation-to-presentation-of-raysearch-s-interim-report-for-the-second-quarter-of-2025,c4208724</link><guid isPermaLink="false">cision5179302</guid><description><![CDATA[Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the second quarter of 2025, on August 8, 2025, at 10.00 am CEST. The report will be published on August 8, 2025, at 07.45 am and will be available together with presentation slides on raysearchlabs.com. Johan Löf, founder and CEO, and Nina Grönberg, CFO, will present the company's development in a webcast. After the presentation (held in English) there is the opportunity to ask questions.

Link to webcast: RaySearch Q2, 2025  (https://events.teams.microsoft.com/event/3be4808f-87b1-4c7d-bed2-]]></description><pubDate>Fri, 18 Jul 2025 07:22:07 GMT</pubDate></item><item><title>RaySearch releases RayCare v2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-releases-raycare-v2025,c4170214</link><guid isPermaLink="false">cision5081299</guid><description><![CDATA[RaySearch Laboratories AB (publ) announces the release of RayCare®* v2025, the latest version of its next-generation oncology information system. The new release delivers powerful functionality enhancements that streamline clinical workflows, improve data management, and strengthen interoperability across the treatment chain.

RayCare v2025 introduces several key innovations designed to simplify daily work for oncology professionals. Seamless integration with Microsoft Word now allows users to generate and update patient-related documents directly within the patient chart – supporting]]></description><pubDate>Fri, 27 Jun 2025 11:00:00 GMT</pubDate></item><item><title>RayStation used for pioneering clinical milestone at Helsinki University Hospital – first treatment with accelerator-based BNCT in Europe</title><link>https://news.cision.com/raysearch-laboratories/r/raystation-used-for-pioneering-clinical-milestone-at-helsinki-university-hospital---first-treatment-,c4164214</link><guid isPermaLink="false">cision5072559</guid><description><![CDATA[RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' accelerator-based boron neutron capture therapy (BNCT), carried out on a patient at Helsinki University Hospital in Finland.

RayStation supports BNCT planning by its suite of tools for patient modelling, plan setup and plan evaluation. In addition, there are specific adaptations for use with the Neutron Therapeutics machine including seamless connection to the BNCT dose engine provided by Neutron]]></description><pubDate>Mon, 16 Jun 2025 07:37:46 GMT</pubDate></item><item><title>RaySearch to present advanced software innovations for particle therapy at PTCOG 63</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-to-present-advanced-software-innovations-for-particle-therapy-at-ptcog-63,c4157801</link><guid isPermaLink="false">cision5063602</guid><description><![CDATA[RaySearch Laboratories AB (publ) will exhibit at PTCOG 63, held June 3–6, 2025, in Buenos Aires, Argentina. At booth #08, the company will showcase its latest software innovations driving the future of particle therapy.
RaySearch’s portfolio – including RayStation®*, RayCare®*, RayIntelligence®, and RayCommand®* – continues to lead in transforming complex treatment systems into intelligent, adaptive cancer care.

Featured highlights in particle therapy

  · Proton arc therapy: Now clinically applied, with enhanced dose conformity and organ sparing.
  · Monte Carlo dose engine: Ultra-]]></description><pubDate>Mon, 02 Jun 2025 10:51:38 GMT</pubDate></item><item><title>Bulletin from the Annual General Meeting 2025</title><link>https://news.cision.com/raysearch-laboratories/r/bulletin-from-the-annual-general-meeting-2025,c4154251</link><guid isPermaLink="false">cision5058629</guid><description><![CDATA[The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025, in Stockholm, Sweden. The following resolutions were adopted.
It was resolved to re-elect Carl Filip Bergendal, Johan Löf, Günther Mårder, Britta Wallgren and Hans Wigzell as Board members of the company and to re-elect Hans Wigzell as Chairman of the Board.

The Annual General Meeting adopted the balance sheets and income statements and discharged the members of the Board and the CEO from liability. It was resolved, in accordance with the Board's proposal, on a dividend of SEK 3 per share and]]></description><pubDate>Thu, 22 May 2025 18:35:22 GMT</pubDate></item><item><title>Interim report January 1 – March 31, 2025</title><link>https://news.cision.com/raysearch-laboratories/r/interim-report-january-1---march-31--2025,c4147874</link><guid isPermaLink="false">cision5049290</guid><description><![CDATA[FIRST QUARTER (JANUARY - MARCH 2025)

  · Order intake amounted to SEK 409.6 M (238.5)
  · Net sales amounted to SEK 331.7 M (257.2)
  · Operating profit amounted to SEK 74.8 M (45.8)
  · Profit after tax amounted to SEK 56.8 M (36.7)
  · Earnings per share before/after dilution amounted to SEK 1.66 (1.07)
  · Cash flow from operating activities amounted to SEK 146.8 M (167.3)
  · Order backlog amounted to SEK 1,734.4 M (1,848.0) at the end of the period.

SIGNIFICANT EVENTS DURING THE FIRST QUARTER

  · The number of radiation therapy clinics worldwide that have chosen]]></description><pubDate>Fri, 09 May 2025 05:45:00 GMT</pubDate></item><item><title>RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-laboratories-and-vision-rt-present-innovations-in-surface-guided-treatment-planning-at-est,c4144768</link><guid isPermaLink="false">cision5044521</guid><description><![CDATA[At this week’s ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integration of MapRT with RayStation®* treatment planning system. This integration enables full access to the MapRT clearance map in RayStation to guide the user during treatment planning in choosing beam trajectories clear from collisions between the treatment unit, patient and couch.
During CT simulation, MapRT (https://visionrt.com/our-solutions/maprt/) cameras capture the entire surface of the patient, along with any immobilization]]></description><pubDate>Sat, 03 May 2025 06:00:00 GMT</pubDate></item><item><title>The Royal Marsden first center in the world to treat a patient using the new adaptive replanning module in RayStation for online adaptive radiotherapy treatment</title><link>https://news.cision.com/raysearch-laboratories/r/the-royal-marsden-first-center-in-the-world-to-treat-a-patient-using-the-new-adaptive-replanning-mod,c4144507</link><guid isPermaLink="false">cision5044252</guid><description><![CDATA[RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and groundbreaking workflow, enabled by the new adaptive replanning module, released in the latest version of RayStation®*. The treatment was carried out with Accuray’s treatment machine Radixact®, RayStation, and The Royal Marsden’s existing oncology information system. The first patient was successfully treated in March 2025.
With this treatment, The Royal Marsden has demonstrated the effectiveness and efficiency of the new module in]]></description><pubDate>Fri, 02 May 2025 13:00:00 GMT</pubDate></item><item><title>RaySearch to showcase its latest innovations in RayStation, RayCare, and RayIntelligence at ESTRO 2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-to-showcase-its-latest-innovations-in-raystation--raycare--and-rayintelligence-at-estro-20,c4144412</link><guid isPermaLink="false">cision5044087</guid><description><![CDATA[RaySearch Laboratories AB (publ) is proud to announce our participation at ESTRO in Vienna, Austria, May 3-5, where we will present groundbreaking innovations under our new global campaign Coding Energy to End Cancer. (https://www.raysearchlabs.com/estro-2025/) Attendees will be able to book demonstrations of the treatment planning system RayStation®*, the oncology information system RayCare®*, and the cloud-based oncology analytics system RayIntelligence® during the congress. Demonstrations are booked at booth #800.
At ESTRO 2025, RaySearch will spotlight five key focus areas critical to]]></description><pubDate>Fri, 02 May 2025 10:37:17 GMT</pubDate></item><item><title>RaySearch releases RayStation v2025</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-releases-raystation-v2025,c4143876</link><guid isPermaLink="false">cision5043870</guid><description><![CDATA[RaySearch Laboratories AB (publ) announces the launch of RayStation®* v2025, the latest version of the company’s innovative treatment planning system. The new version comes with fast automated treatment planning using machine learning** and using the ECHO algorithm, as well as extended support for planning of treatments for patients in an upright position.
Fast automatic treatment planning simplifies the workflow to create personalized treatment plans and significantly reduces the time required compared to manual treatment planning. Further, it leads to more consistent and reproducible]]></description><pubDate>Fri, 02 May 2025 06:30:00 GMT</pubDate></item><item><title>Clarification and supplementation of previous press release on publication of RaySearch Annual Report for 2024</title><link>https://news.cision.com/raysearch-laboratories/r/clarification-and-supplementation-of-previous-press-release-on-publication-of-raysearch-annual-repor,c4140978</link><guid isPermaLink="false">cision5039244</guid><description><![CDATA[Earlier today, RaySearch Laboratories AB (publ) published its annual report for 2024.

In the press release it was stated that the remuneration report was also published, which was incorrect. 

The remuneration report will be published no later than May 1.

The annual report in ESEF format is also attached to this press release. RaySearch's annual report for 2024 is available on RaySearch's website under the Investors section.]]></description><pubDate>Fri, 25 Apr 2025 15:19:43 GMT</pubDate></item><item><title>Invitation to presentation of RaySearch’s interim report for the first quarter of 2025</title><link>https://news.cision.com/raysearch-laboratories/r/invitation-to-presentation-of-raysearch-s-interim-report-for-the-first-quarter-of-2025,c4146253</link><guid isPermaLink="false">cision5038912</guid><description><![CDATA[Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2025, on May 9, 2025, at 10.00 am CEST. The report will be published on May 9, 2025, at 07.45 am and will be available together with presentation slides on raysearchlabs.com (https://www.raysearchlabs.com/). Johan Löf, founder and CEO, and Nina Grönberg, CFO, will present the company's development in a webcast. After the presentation (held in English) there is the opportunity to ask questions.

Link to webcast: RaySearch (https://events.teams.microsoft.com/event/14286de3-]]></description><pubDate>Fri, 25 Apr 2025 09:45:00 GMT</pubDate></item><item><title>RaySearch publishes Annual Report for 2024</title><link>https://news.cision.com/raysearch-laboratories/r/raysearch-publishes-annual-report-for-2024,c4140308</link><guid isPermaLink="false">cision5038483</guid><description><![CDATA[Today, RaySearch Laboratories AB (publ) publishes its Annual Report and Remuneration Report for the financial year 2024. The reports are held available at RaySearch’s website, under the section Investors. 

This information is information that RaySearch Larboratiories AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 07:50 am CEST, on April 25, 2025.]]></description><pubDate>Fri, 25 Apr 2025 05:50:00 GMT</pubDate></item><item><title>Odense University Hospital selects RayStation</title><link>https://news.cision.com/raysearch-laboratories/r/odense-university-hospital-selects-raystation,c4139767</link><guid isPermaLink="false">cision5037913</guid><description><![CDATA[RaySearch Laboratories AB (publ) announces that Odense University Hospital (OUH), which is part of the South Denmark Region, has placed an order for RayStation®*.
The radiotherapy center at OUH is known for being at the forefront of automated solutions to provide high-quality care in an efficient way, including the ability to automatically generate treatment plans.

With the introduction of RayStation, the clinic is now taking the next step by further developing automation to cover all aspects of the treatment planning process—from initial planning to finalized treatment plans. RayStation]]></description><pubDate>Thu, 24 Apr 2025 11:21:19 GMT</pubDate></item><item><title>Invitation to Annual General Meeting 2025</title><link>https://news.cision.com/raysearch-laboratories/r/invitation-to-annual-general-meeting-2025,c4134879</link><guid isPermaLink="false">cision5031360</guid><description><![CDATA[The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Thursday, May 22, 2025 at 6.00 p.m. at the company's office at Eugeniavägen 18C, Stockholm, Sweden. Registration will start at 5.00 p.m. and light refreshments will be served.
The Board of Directors has decided that the shareholders also shall be able to exercise their voting rights by postal voting before the Annual General Meeting, as instructed below.

Right to participate and notice

Participation at the meeting venue

A person]]></description><pubDate>Mon, 14 Apr 2025 08:00:00 GMT</pubDate></item><item><title>Share conversion in RaySearch Laboratories AB (publ)</title><link>https://news.cision.com/raysearch-laboratories/r/share-conversion-in-raysearch-laboratories-ab--publ-,c4127866</link><guid isPermaLink="false">cision5021033</guid><description><![CDATA[According to the articles of association of RaySearch Laboratories AB (publ), owners of Class A shares have the right to have such shares converted to Class B shares. Such a conversion reduces the number of votes in the company.
In March 2025, 2,000,000 Class A shares were converted to Class B shares, at the request of a shareholder. The total number of votes in RaySearch thereafter amounts to 85,177,548 votes. The total number of registered shares in RaySearch amounts to 34,282,773 shares, out of which 5,654,975 are Class A shares and 28,627,798 are Class B shares.

This information is]]></description><pubDate>Mon, 31 Mar 2025 14:45:00 GMT</pubDate></item><item><title>Completed placing of shares in RaySearch Laboratories AB (publ)</title><link>https://news.cision.com/raysearch-laboratories/r/completed-placing-of-shares-in-raysearch-laboratories-ab--publ-,c4120829</link><guid isPermaLink="false">cision5010088</guid><description><![CDATA[NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE OR MAY BE UNLAWFUL.PLEASE REFER TO THE SECTION "IMPORTANT NOTICE" AT THE END OF THIS PRESS RELEASE.
Following the press release issued today, Johan Löf (the "Seller"), has successfully completed the sale of 2,000,000 class B shares in RaySearch Laboratories AB (publ) ("RaySearch Laboratories" or the "Company") corresponding to 5.8 per cent of the share capital of the Company (]]></description><pubDate>Tue, 18 Mar 2025 20:30:00 GMT</pubDate></item></channel></rss>